{"name":"Mesoblast International Sàrl","slug":"mesoblast-international-s-rl","ticker":"","exchange":"","domain":"","description":"Mesoblast International Sàrl is a biotechnology company focused on developing cell-based therapies for various medical conditions. The company has a primary focus on regenerative medicine and has one discontinued drug in its pipeline, autologous expanded mesenchymal stem cells OTI-010.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQVEdWY19ONURpSzFuSU80eUZQWWYyMjViZ2VGZDgzUGVtSUFqRnJHaFdJT1NyQ1E1Q2Q3ZTJ1ejB5YS1FSFFkMDJaR0pBZXpWSFpkdkphOHVpUzE4MTRMMkRLWXk4LXdKZE1va0JYejRBaWFlWUNsMmNvSXYycXdlaE1sUWRlZVljV3ZhcHBJeWQ5QUNlVVow0gGcAUFVX3lxTE1IbWxwWDJSTU96UHFyU3NXYmtza3hTUVJBanVnZV83Vk9mWHBOU2Z2UnZDY1B6S0p1b1l2WnFOV3RUcXlteTdqZmFCMGVwWEgydTFrN2lIWnYxdVNtQ1B6dHVNalVhQTFrbjVEa1FJZ1ZZNWx2dTQ0QS1oU2JmcUcxQzNnbjJzYk5ac2RwNkRENjVMVVItZEl6OHJ2cg?oc=5","date":"2015-09-11","type":"trial","source":"BioInformant","summary":"Breakdown of Mesenchymal Stem Cell Clinical Trials, by Phase, Geography, Sponsors, and More - BioInformant","headline":"Breakdown of Mesenchymal Stem Cell Clinical Trials, by Phase, Geography, Sponsors, and More","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}